B-UP is a lock to advance to Phase 2b. Cha-ching!
Quote:J&J will pay Protagonist $125 million if it moves the drug into phase 2b and a further $200 million if it sticks with the asset after getting a look at data from the trial.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links